Medworxx announces highest quarter of revenues achieved since the company’s inception–and continues to build on its strategic goal of becoming the patient flow management platform in the hospital marketplace.
Medworxx Solutions Inc. Files Second Quarter 2012 Financial Statements and Management’s Discussion and Analysis
Medworxx Solutions Inc. (the "Company")(TSX VENTURE:MWX) announced today that it has filed with the Canadian securities authorities its (Unaudited), and report for the three and six month interim periods ended June 30, 2012. These documents may be viewed under the Company's profile at .
Highlights of the results include:
“Boosted by another record quarter that demonstrates strong growth for Medworxx, our momentum for 2012 continues to build,” says Dan Matlow, President and CEO, Medworxx, referring to the company’s increase in revenue and licensed beds.
Medworxx Patient Flow, including Medworxx Utilization Management and Medworxx Bed Board, provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow – optimal for healthcare systems addressing issues of overcapacity, wait times and care coordination. Spurred onwards by uptake of the patient flow solution in 21,000 acute care beds in Canada and United Kingdom’s National Health System (NHS), and a recent launch into the United States, Medworxx is expanding to leverage growth that includes agreements with four of Canada’s 10 Provinces and also includes 1,000 beds in the UK NHS Trust.
Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Utilization Management system—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves 30% of the acute care beds in Canada. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange:
The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.